SK Bioscience Co

SK Bioscience Co Inventory

The Inventory of SK Bioscience Co (302440.KS) as of Oct 17, 2026 is 189.20 B KRW. In the previous year, Inventory was 211.13 B KRW — a change of -10.38% (lower).

Inventory

189.20 BKRW

YoY

-10.38%

Last updated:

Inventory of SK Bioscience Co is 2025 189.20 B KRW. Inventory of SK Bioscience Co was 2024 211.13 B KRW. It decreases by -10.38% lower compared to the previous year.

The SK Bioscience Co Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2018
31.88 B KRW
Jan 1, 2019
36.38 B KRW
Jan 1, 2020
70.28 B KRW
Jan 1, 2021
135.05 B KRW
Jan 1, 2022
187.41 B KRW
Jan 1, 2023
80.65 B KRW
Jan 1, 2024
211.13 B KRW
Jan 1, 2025
189.20 B KRW
The SK Bioscience Co Inventory history
YEARInventoryYoY
189.20 BKRW-10.38%
211.13 BKRW+161.78%
80.65 BKRW-56.97%
187.41 BKRW+38.77%
135.05 BKRW+92.17%
70.28 BKRW+93.18%
36.38 BKRW+14.12%
31.88 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SK Bioscience Co Stock analysis

What does SK Bioscience Co do? SK Bioscience Co Ltd is a South Korean biotechnology company headquartered in Seongnam, Gyeonggi-Do. The company went public on March 18, 2021, with its stock listed on the Korean Stock Exchange under the ticker 302440.KS. It operates within the health care sector, specifically in the biotechnology industry. SK Bioscience employs 1,067 people and focuses on the development and distribution of bio and vaccine products. The company distributes its products both domestically and internationally. While specific product names are mentioned in unverified sources, the company is known to be involved in the production of vaccines and infusion solutions. It also engages in technology export business, though detailed information about its technology or export markets is not provided. The company's website is https://www.skbioscience.co.kr/, where further information about its operations and products may be available. SK Bioscience does not disclose specific details about its product lines beyond the general categories of vaccines and infusion solutions, and it does not provide information on acquisitions, founding year, or key personnel. The company's activities are centered around biotechnology and healthcare, with a focus on vaccine development and distribution. Its market presence spans both domestic and international markets, though specific regions or countries are not specified. The company's financial data, including revenue and market capitalization, is not included in the provided information. SK Bioscience is a publicly traded company with a focus on biotechnology and healthcare innovation. SK Bioscience Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SK Bioscience Co stock

Inventory of SK Bioscience Co is 189.20 B KRW in 2025.

Inventory of SK Bioscience Co changed from 211.13 B KRW to 189.20 B KRW, representing a -10.38% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Inventory SK Bioscience Co since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's SK Bioscience Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — SK Bioscience Co

All Key Metrics — SK Bioscience Co